Understanding Low and Intermediate-Risk Bladder Cancer Management

Stay up to date in your bladder cancer practice with this insightful episode of the BackTable Urology podcast, developed in collaboration with the Society of Urologic Oncology. Dr. Betsy Koehne (University of Wisconsin) and Dr. Amir Salmasi (UC San Diego) talk through the contemporary management of low and intermediate-risk non-muscle-invasive bladder cancer.

---

SYNPOSIS

The doctors explore the challenges and nuances of patient communication, intravesical therapy, and postoperative surveillance. They also cover emerging treatments and clinical trials that hold promise for improving patient outcomes and quality of life. Emphasis is placed on the distress experienced by patients and the need for personalized treatments.

---

TIMESTAMPS

00:00 - Introduction

01:51 - Initial Consultation

08:01 - TURBT Procedure Insights

23:14 - Managing Low and Intermediate Risk Bladder Cancer

26:47 - Recurrence and Surveillance Strategies

27:48 - Prognostication Tools

30:10 - Intravesical Chemotherapy Options

33:24 - High Grade Tumors

42:33 - Clinical Trials and Emerging Therapies

49:19 - Concluding Thoughts